Navigation Links
Nobel Prize-Winning Discovery
Date:12/20/2007

Biomedical Research Is a Winning Pursuit

WASHINGTON, Dec. 19 /PRNewswire-USNewswire/ -- The following release was issued by Frankie L. Trull President, Foundation for Biomedical Research:

Biomedical research the National Institutes of Health deemed "not worthy of pursuit" in 1980 earned Mario Capecchi a Nobel Prize last month.

Despite the early setback, the Harvard-educated genetics professor persisted toward his goal. Within four years, Capecchi filed another NIH grant proposal, this time armed with further evidence of what he had sought to prove, that something called gene targeting was possible in mammals.

The Institutes, in responding to Capecchi's new request, said, "We are glad that you didn't follow our advice."

A lot of people feel the same way. Twenty years after his breakthroughs at the University of Utah's School of Medicine, it is clear how far researchers' understanding of human disease has progressed.

Another researcher, Oliver Smithies, who was concurrently pursuing a similar mission at the University of North Carolina at Chapel Hill, shares the 2007 Nobel Prize in Physiology or Medicine. The prize also belongs to Martin J. Evans of Cardiff University in Wales, who demonstrated that genes from embryonic stem cells can be inherited.

Want to figure out what role a certain gene plays in susceptibility to cancer? Or what another gene has to do with aging? Due to Capecchi's work, genetic modifications in mice make it possible to render selected genes inactive, thereby providing information about their functions.

Genes linked with hereditary conditions can be deactivated, or turned "off," in "knock-out mice." Researchers are already capable of knocking out more than 10,000 genes. In case you're not counting, this means researchers are halfway to uncovering the function of every gene common among mammals.

Conversely -- and here's where it gets really interesting -- scient
'/>"/>

SOURCE Foundation for Biomedical Research
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
2. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
3. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
4. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
5. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
6. ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure, Atrial Fibrillation, and Ventricular Arrhythmia
7. Five Clinical Studies to Receive $2.5 Million Under Foundations 2007 Clinical Discovery Program
8. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
9. FASgen Announces New Discovery for Treatment of Stroke

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...irstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) tod...xecutive Officer, and Greg Browne, Chief Financial...ffray Health Care Conference in New York on Wednes...ence session and webcast will be audio only and no...ill host a webcast of the presentation live and by...
(Date:11/20/2009)...swire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin ...known as DOR BioPharma, Inc., a late-stage biotech... a consortium to develop thermostable technology t...nes. Soligenix received a $9.4 million grant from ...iseases (NIAID), a division of the National Instit...
(Date:11/19/2009)...swire-FirstCall/ -- In a series of new initiatives...ration (Nasdaq: HSKA ) ("Heska" or the "Company")...d website. The upgraded site is the result of sev... align the site with the company,s new brand image...www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ...
Breaking Medicine Technology:Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3New Technique Offers Hope for Kids With Immune Deficiency 55986 1New Technique Offers Hope for Kids With Immune Deficiency 55986 2Dr William J Robbins Joins Anpath Group Inc Board of Directors 55984 1Dr William J Robbins Joins Anpath Group Inc Board of Directors 55984 2Dr William J Robbins Joins Anpath Group Inc Board of Directors 55984 3eCardio Included on Inc Magazines 28th Annual List of Americas Fastest Growing Private Companies the Inc 500 55980 1eCardio Included on Inc Magazines 28th Annual List of Americas Fastest Growing Private Companies the Inc 500 55980 2
...ented today from METEOR (Measuring Effects on inti... showed CRESTOR(R) (rosuvastatin calcium) 40,mg sl...ness (CIMT) in four,patient populations at varying...b- study was conducted in subjects defined by the ...n two or two or more risk factors (RF),and either ...
... Inc. today,announced that the investigational age...to normal heart rhythm (sinus rhythm, or SR) in,pa...onary artery bypass,graft (CABG) or valvular surge...terized by an irregular heart rhythm and a high he...annual meeting of the American Heart,Association. ...
Other Medicine Technology:New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 2New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 3New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 4New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 5New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease 6Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery 2Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery 3
(Date:11/20/2009)... Following a recall by Unilever The...sale Shedd,s Country Crock ® Side Dishes DELU... ® Side Dishes DELUXE Four Cheese Pasta due t...wing code dates and UPCs are affected: ,, Shed...r Broccoli Rice 21 oz, UPC 027400218316, Best By N...
(Date:11/20/2009)...swire-USNewswire/ -- The American Dental Associati...stration (FDA) to establish appropriate classifica... concern about the safety of whitening products th...rofessional consultation or examination by a denti...hemically based tooth whitening or bleaching agent...
(Date:11/20/2009)...v. 20 Samuel Gladding i...hat it means to be "happy" during the holidays. As...y in family counseling and chair of the Department... says research shows that it is the pressure to be...sion during the holidays. ,, That,s why he,s ch...
(Date:11/20/2009)...vember 20 in the Journal of the National Cancer I...s that often appear in news coverage of cancer res...e media and journals to help alleviate the problem...oshin, M.D., M.S., of Center for Medicine and the ... and Clinical Practice in New Hampshire, and Barne...
(Date:11/20/2009)...0, 2009Emergency medical service (EMS) providers i...rdiac arrests each year. Only 5 to 10 percent of ...tter quality cardiopulmonary resuscitation (CPR) p...ated with better patient outcome. The Resuscitati...al research network to study prehospital treatment...
Breaking Medicine News(10 mins):Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...f patients who undergo male to female sex-change s...t that complications are common, according to a st... the urology journal BJU International. , A rese...atients who had undergone surgery and 70 who took ...
...lif., Sept. 20 Cardiva Medical, Inc.,a privately ...Augustine,Lien, Chairman and CEO, will present at ...sday, September 25th in New York City. Notably, th...learance. This new product builds on the success o...
... 20 The American Red Cross,and American Heart Ass...n,that would designate the first week of June as "...utomated External Defibrillator (AED) Week." The,b...ty of CPR and AED training and use to reduce death...
...utive and Current Banfield President Succeeds Scot...PORTLAND, Ore., Sept. 19 Effective September 19, ... Officer of Banfield, The Pet,Hospital(R), succeed...,President, Chief Operating Officer and Acting CEO...
... Leader of the Global Breast Cancer Movement, Rece... DALLAS, Sept. 19 Ambassador Nancy G. Brinker, fo...largest breast cancer,organization, and recently a...bin/prnh/20070122/NYM084LOGO ) Each year, Forbes ...
...., Sept. 19 Neurobiological,Technologies, Inc. an...e,fiscal year ended June 30, 2007, included in the...tember 13, 2007, contain a going concern,qualifica...short term investments of approximately $8.9 milli...
Other Medicine News:Health News:Most patients who have male-to-female sex-change surgery are happy, despite complications 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 3Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 4Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 5Health News:National CPR/AED Awareness Week Introduced in Congress 2Health News:National CPR/AED Awareness Week Introduced in Congress 3Health News:Largest Privately-Owned Veterinary Practice in the World, Banfield, the Pet Hospital(R), Appoints New Chief Executive Officer 2Health News:Forbes Honors Susan G. Komen for the Cure Founder as Trailblazer 2Health News:Forbes Honors Susan G. Komen for the Cure Founder as Trailblazer 3Health News:Neurobiological Technologies Reports Going Concern Qualification 2
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
Medicine Products: